Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
08/2007
08/23/2007US20070197621 Method for the treatment of CNS disorders with substituted 2-imidazoles or imidazole derivatives
08/23/2007US20070197620 Methods for treating CNS disorders with bicyclo-substituted 2-imidazoline and 2-imidazoles
08/23/2007US20070197619 Ion Channel Modulators
08/23/2007US20070197569 Method for treating central nervous system disorders with substituted 2-imidazoline derivatives
08/23/2007US20070197522 Dpp-iv inhibitors
08/23/2007US20070197513 calcium channel modulator; [[1-(4-{2-[1-(4-Chloro-phenyl)-2-(2-methoxy-phenyl)-1H-imidazol-4-yl]-ethyl}-(4-fluoro-phenyl)-methyl-amine; analgesic, antidiabetic agent; angina, hypertension, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
08/23/2007US20070196903 Overcoming DAPA aminotransferase bottlenecks in biotin vitamers biosynthesis
08/22/2007EP1819721A1 Microcin b17 analogs and methods for their preparation and use
08/22/2007EP1819682A1 Symmetrical cationic tetraazo compounds, for dyeing keratin fibres
08/22/2007EP1819330A1 5-carboxamido substitued thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family
08/22/2007EP1699900A4 Composition and method for preventing fouling in (meth)acrylic acid processes
08/22/2007EP1124824B1 Chromenone and chromanone derivatives as integrin inhibitors
08/22/2007CN1332953C Method for preparing amino formyl imidazole
08/22/2007CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
08/22/2007CN1332942C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
08/22/2007CN101023069A 苯甲酰基取代的丝氨酸酰胺 Benzoyl substituted serine amide
08/22/2007CN101022728A Imidazole compounds
08/22/2007CN101022727A Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof
08/22/2007CN101020663A Climbazole synthesizing process
08/21/2007US7259271 [4-(tert-butyldimethylsilanyloxy)-3-oxobutyl]methylcarbamic acid tert-butyl ester; (R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-amine; for the treatment of cardiovascular disorders such as hypertension and chronic heart failure
08/21/2007CA2465078C Method of releasing gas or vapor from a solid material
08/21/2007CA2271366C Method for producing potassium oxonate
08/21/2007CA2158487C Weakly basic polymerizable monomers and polymers prepared therefrom
08/16/2007WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
08/16/2007WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate
08/16/2007WO2007090793A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
08/16/2007WO2007090733A1 Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists
08/16/2007WO2007070826B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
08/16/2007US20070191612 Needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide
08/16/2007US20070191443 Methods and materials for assessing prostate cancer therapies and compounds
08/16/2007US20070191383 Mtp inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles
08/16/2007US20070191358 Novel piperidine derivative for the treatment of depression
08/16/2007US20070190659 Method for analyzing n-terminal protein adducts
08/16/2007US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds
08/16/2007CA2641501A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
08/16/2007CA2637768A1 Benzamide and heteroarene derivatives
08/15/2007EP1818336A1 2,2-bis-(4-hydroxyphenyl)-alkyl onium salt and a process for the preparation thereof
08/15/2007EP1818333A1 Vanilloid receptor ligands and their use in treatments
08/15/2007EP1817305A2 Compounds for the treatment of cns and amyloid associated diseases
08/15/2007EP1353669B1 Method for treating glaucoma
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
08/15/2007CN101018761A Methods and compositions for modulating sphingosine-1-phosphate(S1P) receptor activity
08/15/2007CN101016264A Nitroimidazole derivative for treatment, preparing method and use
08/14/2007US7257287 Optical interleaver
08/14/2007US7256208 Monocyclic N-Aryl hydantoin modulators of androgen receptor function
08/14/2007US7256205 2-Aminothiazole histamine H2 receptor antagonists such as famotidine or nizatidine to which is linked at least one NO and/or NO2 group; treating inflammations including gastrointestinal disorders and reducing the gastrointestinal toxicity associated with the use of NSAIDS
08/14/2007CA2281708C Process for preparing eprosartan
08/09/2007WO2007089069A1 Phenyl imidazol sulfonamide derivatives, the preparation method thereof and the whitening cosmetic composition containing the same
08/09/2007WO2007088703A1 Dye laser medium, dye laser apparatus and laser sensor
08/09/2007WO2007087906A1 Fungicide n-cycloalkyl-benzyl-amide derivatives
08/09/2007WO2007072080A3 Heterocycle substituted ketone derivatives as histone deacetylase (hdac) inhibitors
08/09/2007US20070185332 Made by reacting a cyano compound with a silylalkylisocyanide compound; silylimidazole ;
08/09/2007US20070185181 Treatment or prevention of hypotension and shock
08/09/2007US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors
08/09/2007US20070185136 Sulphonamide derivatives, their preparation and their therapeutic application
08/09/2007US20070185109 Idene derivatives and process for the preparation thereof
08/09/2007DE102006005103A1 Oxonium- und Sulfoniumsalze Oxonium and sulfonium salts
08/09/2007CA2632870A1 Fungicide n-cycloalkyl-benzyl-amide derivatives
08/08/2007EP1381595B1 Bis(trifluoromethyl)hydantoins as intermediates for pharmaceutically active ingredients
08/08/2007CN1330657C Novel piperidine and piperazine derivatives
08/08/2007CN1330641C Activator for peroxisome proliferator-responsive receptor delta
08/08/2007CN1330638C Substituted imidazolidine derivatives, their prepn., their use and pharmaceutical prepn. comprising them
08/08/2007CN1330637C Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents
08/08/2007CN1330238C Composition for controlling harmful bio-organisms and method therefor
08/08/2007CN101014581A Novel piperidine derivative for the treatment of depression
08/08/2007CN101014565A Diarylsulfones as 5-HT2a antagonists
08/08/2007CN101014347A Anti-inflammatory agents
08/08/2007CN101012223A Ornidazole derivative for treatment, preparing method and use
08/08/2007CN101012199A Method for synthesizing imidazole butanol
08/08/2007CN101012198A Chiral and non-chiral diimidazolinylbenzene compounds and synthesis method
08/08/2007CN101012193A Novel CB 1 receptour inverse agonists
08/08/2007CN101012174A Halogenating agents
08/08/2007CN101012170A N-arylation method in water solution
08/07/2007US7253289 reacting formaldehyde with alkylamine; acidification in water, glyooxal solution; separation
08/07/2007US7253283 9-[4-[4-[[2-(2,2,2-trifluoroethoxy)benzoyl]amino]-1-piperidinyl]butyl]-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide; non-steroidal modulator of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity, obesity, diabetes, inflammatory and immune diseases
08/07/2007US7253200 Using in leukocyte recruitment inhibition, in modulating H4 receptor expression, and in treating conditions such as inflammation, H4 receptor-mediated conditions
08/07/2007US7253199 Azole derivatives and pharmaceutical compositions containing them
08/07/2007US7253194 Compounds and inhibitors of phospholipases
08/07/2007US7253173 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate
08/07/2007US7252791 sulfonic acids and salts such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers
08/02/2007WO2007087135A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
08/02/2007WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K
08/02/2007WO2007086354A1 Novel histidine derivative
08/02/2007WO2007085558A1 Use of 2-imidazoles for the treatment of cns disorders
08/02/2007WO2007085556A2 Use of 4-imidazole derivatives for cns disorders
08/02/2007WO2007085357A1 Cyclourea compounds as calcium channel blockers
08/02/2007WO2007073503A8 Indane modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/02/2007WO2007063702A3 Iminopropene compound and use thereof
08/02/2007WO2007052073A3 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
08/02/2007WO2006135640A3 Process for the synthesis of organic compounds
08/02/2007US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
08/02/2007US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use
08/02/2007CA2637312A1 Use of substituted 2-imidazole of imidazoline derivatives
08/02/2007CA2637308A1 Use of 4-imidazole derivatives for cns disorders
08/02/2007CA2637261A1 Use of 2-imidazoles for the treatment of cns disorders
08/02/2007CA2636931A1 Piperazines and piperidines as mglur5 potentiators
08/02/2007CA2636787A1 Novel histidine derivatives
08/01/2007EP1813596A1 Process for producing alpha, alpha- difluoroamine
08/01/2007EP1812425A2 C-fms kinase inhibitors
08/01/2007EP1812421A2 Anthranilamide insecticides
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 345